Obesity Reviews SCIE

国际简称：OBES REV 参考译名：肥胖评论

主要研究方向：医学-内分泌学与代谢非预警期刊审稿周期：约1月

《肥胖评论》(Obesity Reviews)是一本由Wiley-Blackwell Publishing Ltd出版的以医学-内分泌学与代谢为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本混合期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
125 年发文量
8 IF影响因子
混合是否OA
137 H-index
2000 创刊年份
Monthly 出版周期
English 出版语言

Obesity Reviews is a monthly journal publishing reviews on all disciplines related to obesity and its comorbidities. This includes basic and behavioral sciences, clinical treatment and outcomes, epidemiology, prevention and public health. The journal should, therefore, appeal to all professionals with an interest in obesity and its comorbidities. Review types may include systematic narrative reviews, quantitative meta-analyses and narrative reviews but all must offer new insights, critical or novel perspectives that will enhance the state of knowledge in the field. Prevalence studies that compare (review) trends across countries or regions or across ethnic groups or relevant subpopulations and provide novel insights and/or conclusions will be considered. The journal also invites short reviews presenting original or challenging theories, hypotheses or alternative interpretations of findings. Case reports presenting important and novel information and Letters to the Editor are also welcome. The journal will contribute to education and inter-professional developments by planning pro and con reviews on current controversies.

The editorial policy is to publish high quality peer-reviewed manuscripts that provide needed new insight into all aspects of obesity and its related comorbidities while minimizing the period between submission and publication.

Obesity Reviews is the official reviews journal of the World Obesity Federation. A special subscription rate is available for individuals who are members of their national associations under the umbrella of WO.

[ 查看全部 ]

投稿咨询加急咨询

Obesity Reviews期刊信息

ISSN：1467-7881
出版语言：English
是否OA：混合
E-ISSN：1467-789X
出版地区：ENGLAND
是否预警：否
出版商：Wiley-Blackwell Publishing Ltd
出版周期：Monthly
创刊时间：2000
开源占比：0.2819
Gold OA文章占比：40.18%
OA被引用占比：0.2760...
出版国人文章占比：0.09
出版撤稿占比：0
研究类文章占比：11.20%

Obesity Reviews CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

19.3

2.818

2.798

学科类别	分区	排名	百分位
大类：Medicine 小类：Public Health, Environmental and Occupational Health	Q1	8 / 665	98%
大类：Medicine 小类：Endocrinology, Diabetes and Metabolism	Q1	10 / 244	96%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Obesity Reviews中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	1区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	1区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	1区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	1区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	是	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	2区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	1区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	1区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	1区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	2区

Obesity Reviews JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q1	14 / 186	92.7%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q1	20 / 186	89.52%

Obesity Reviews历年数据统计

影响因子

中科院分区

Obesity Reviews中国学者发文选摘

1、Prevalence of anemia and related nutrient deficiencies after sleeve gastrectomy: A systematic review and meta-analysis
Author: Nie, Yuntao; Tian, Ziru; Wang, Pengpeng; Liu, Baoyin; Zhang, Nianrong; Zhou, Biao; Wang, Siqi; Hei, Xiaofan; Meng, Hua

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1111/obr.13516
2、Regulatory role of atrial natriuretic peptide in brown adipose tissue: A narrative review
Author: Lu, Guanhua; Hu, Ruixiang; Tao, Tian; Hu, Min; Dong, Zhiyong; Wang, Cunchuan

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1111/obr.13522
3、Two-sided roles of adipose tissue: Rethinking the obesity paradox in various human diseases from a new perspective
Author: Pan, Jing; Yin, Jianqiong; Gan, Lu; Xue, Jianxin

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 1, pp. -. DOI: 10.1111/obr.13521
4、Deciphering the obesity paradox in the elderly: A systematic review and meta-analysis of sarcopenic obesity
Author: Liu, Chaoran; Wong, Pui Yan; Chung, Yik Lok; Chow, Simon Kwoon-Ho; Cheung, Wing Hoi; Law, Sheung Wai; Chan, Juliana Chung Ngor; Wong, Ronald Man Yeung

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 2, pp. -. DOI: 10.1111/obr.13534
5、Association of fast-food restaurants with overweight and obesity in school-aged children and adolescents: A systematic review and meta-analysis
Author: Jiang, Jun; Lau, Patrick W. C.; Li, Yanhui; Gao, Di; Chen, Li; Chen, Manman; Ma, Ying; Ma, Tao; Ma, Qi; Zhang, Yi; Liu, Jieyu; Wang, Xingxing; Dong, Yanhui; Song, Yi; Ma, Jun

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 3, pp. -. DOI: 10.1111/obr.13536
6、Fine particulate matter induces adipose tissue expansion and weight gain: Pathophysiology
Author: Della Guardia, Lucio; Wang, Ling

Journal: OBESITY REVIEWS. 2023; Vol. 24, Issue 4, pp. -. DOI: 10.1111/obr.13552
7、Maternal obesity and offspring health: Adapting metabolic changes through autophagy and mitophagy
Author: Wang, Litao; O'Kane, Aislinn M. M.; Zhang, Yingmei; Ren, Jun

Journal: OBESITY REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1111/obr.13567
8、Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials.
Author: Jia Y¹, Lao Y¹, Zhu H¹, Li N¹, Leung SW^1,².

Journal: Obes Rev. 2019 Jan;20(1):1-12. doi: 10.1111/obr.12753. Epub 2018 Sep 17.